Analytical Data
-
Gene name
BH0637
- Application
-
Alternative Names
BH0637; Putative adenine deaminase BH0637; Adenase; Adenine aminase; EC 3.5.4.2
-
Species
Bacillus halodurans
-
Source
E. coli
-
Tag
N- His-SUMO & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9KF49
-
Expression Region
1-328aa
-
Molecular Weight
57.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BH0637 is a recombinant protein derived from the bacterium Burkholderia pseudomallei, which is recognized as a significant human pathogen responsible for melioidosis, a disease that can lead to severe morbidity and mortality. The study of BH0637 is pivotal due to its potential role in understanding the pathogenic mechanisms of Burkholderia pseudomallei and its interactions with the host immune system. This protein is thought to be involved in bacterial virulence, possibly influencing the ability of the pathogen to evade immune responses. Investigating the structure and function of BH0637 could provide insights into its role in the disease process and aid in the development of diagnostic tools and therapeutic strategies. Furthermore, studying this protein may reveal new targets for vaccine development, which is crucial given the increasing incidence of melioidosis in endemic regions and the challenge posed by antibiotic-resistant strains. By elucidating the molecular properties of BH0637 and its impact on host-pathogen interactions, research can contribute to a broader understanding of bacterial pathogenesis and facilitate advancements in clinical management of infections caused by Burkholderia pseudomallei.
